Cargando…

Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau

Intracerebral injection of brain extracts containing amyloid or tau aggregates in transgenic animals can induce cerebral amyloidosis and tau pathology. We extracted pure populations of tau oligomers directly from the cerebral cortex of Alzheimer disease (AD) brain. These oligomers are potent inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lasagna-Reeves, Cristian A., Castillo-Carranza, Diana L., Sengupta, Urmi, Guerrero-Munoz, Marcos J., Kiritoshi, Takaki, Neugebauer, Volker, Jackson, George R., Kayed, Rakez
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3463004/ https://www.ncbi.nlm.nih.gov/pubmed/23050084 http://dx.doi.org/10.1038/srep00700

Ejemplares similares

Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice
por: Lasagna-Reeves, Cristian A, et al.
Publicado: (2011)

α-Synuclein Oligomers Induce a Unique Toxic Tau Strain
por: Castillo-Carranza, Diana L., et al.
Publicado: (2018)

Characterization of tau oligomeric seeds in progressive supranuclear palsy
por: Gerson, Julia E, et al.
Publicado: (2014)

The formation of tau pore-like structures is prevalent and cell specific: possible implications for the disease phenotypes
por: Lasagna-Reeves, Cristian A, et al.
Publicado: (2014)

Tau oligomers in cerebrospinal fluid in Alzheimer's disease
por: Sengupta, Urmi, et al.
Publicado: (2017)

Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage
por: Shafiei, Scott S., et al.
Publicado: (2017)

Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
por: Gerson, Julia E., et al.
Publicado: (2018)

The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy
por: Sengupta, Urmi, et al.
Publicado: (2016)

Tau Oligomers Associate with Inflammation in the Brain and Retina of Tauopathy Mice and in Neurodegenerative Diseases
por: Nilson, Ashley N., et al.
Publicado: (2016)

Immunotherapy for the treatment of Alzheimer’s disease: amyloid-β or tau, which is the right target?
por: Castillo-Carranza, Diana L, et al.
Publicado: (2013)

Formation and Propagation of Tau Oligomeric Seeds
por: Gerson, Julia E., et al.
Publicado: (2013)

The prion-like transmission of tau oligomers via exosomes
por: Jackson, Noel A., et al.
Publicado: (2022)

Cerebral Microvascular Accumulation of Tau Oligomers in Alzheimer’s Disease and Related Tauopathies
por: Castillo-Carranza, Diana L, et al.
Publicado: (2017)

Tau oligomers mediate aggregation of RNA‐binding proteins Musashi1 and Musashi2 inducing Lamin alteration
por: Montalbano, Mauro, et al.
Publicado: (2019)

Tau Oligomers: The Toxic Player at Synapses in Alzheimer’s Disease
por: Guerrero-Muñoz, Marcos J., et al.
Publicado: (2015)

Lysine 63-linked ubiquitination of tau oligomers contributes to the pathogenesis of Alzheimer’s disease
por: Puangmalai, Nicha, et al.
Publicado: (2022)

A native interactor scaffolds and stabilizes toxic ATAXIN-1 oligomers in SCA1
por: Lasagna-Reeves, Cristian A, et al.
Publicado: (2015)

Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to Alzheimer’s disease and frontotemporal dementia
por: Gaikwad, Sagar, et al.
Publicado: (2021)

Toxic Tau Oligomers Modulated by Novel Curcumin Derivatives
por: Lo Cascio, Filippa, et al.
Publicado: (2019)

Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer’s disease, progressive supranuclear palsy and dementia with Lewy bodies
por: Puangmalai, Nicha, et al.
Publicado: (2020)

Polymorphic α-Synuclein Strains Modified by Dopamine and Docosahexaenoic Acid Interact Differentially with Tau Protein
por: Sengupta, Urmi, et al.
Publicado: (2020)

Pathological tau signatures and nuclear alterations in neurons, astrocytes and microglia in Alzheimer's disease, progressive supranuclear palsy, and dementia with Lewy bodies
por: Montalbano, Mauro, et al.
Publicado: (2022)

Polymorphic Alpha-Synuclein Oligomers: Characterization and Differential Detection with Novel Corresponding Antibodies
por: Moore, Kenya, et al.
Publicado: (2023)

RNA-binding proteins Musashi and tau soluble aggregates initiate nuclear dysfunction
por: Montalbano, Mauro, et al.
Publicado: (2020)

Aβ/tau oligomer interplay at human synapses supports shifting therapeutic targets for Alzheimer’s disease
por: Marcatti, Michela, et al.
Publicado: (2022)

Near Infrared Light Treatment Reduces Synaptic Levels of Toxic Tau Oligomers in Two Transgenic Mouse Models of Human Tauopathies
por: Comerota, Michele M., et al.
Publicado: (2018)

Advances and considerations in AD tau-targeted immunotherapy
por: Bittar, Alice, et al.
Publicado: (2019)

Tau Protein: Function and Pathology
por: Rosenmann, Hanna, et al.
Publicado: (2012)

Ataxin-1 oligomers induce local spread of pathology and decreasing them by passive immunization slows Spinocerebellar ataxia type 1 phenotypes
por: Lasagna-Reeves, Cristian A, et al.
Publicado: (2015)

Association of Skin with the Pathogenesis and Treatment of Neurodegenerative Amyloidosis
por: Clos, Audra L., et al.
Publicado: (2012)

Neurotoxic tau oligomers after single versus repetitive mild traumatic brain injury
por: Bittar, Alice, et al.
Publicado: (2019)

Characteristics of Tau Oligomers
por: Ren, Yan, et al.
Publicado: (2013)

Tau Oligomers Neurotoxicity
por: Niewiadomska, Grazyna, et al.
Publicado: (2021)

Oligomeric tau-targeted immunotherapy in Tg4510 mice
por: Schroeder, Sulana, et al.
Publicado: (2017)

Bassoon contributes to tau-seed propagation and neurotoxicity
por: Martinez, Pablo, et al.
Publicado: (2022)

Prospects for strain-specific immunotherapy in Alzheimer’s disease and tauopathies
por: Bittar, Alice, et al.
Publicado: (2018)

Quantification and targeting of elusive neurotoxic amyloid oligomers
por: Bhatt, Nemil, et al.
Publicado: (2022)

Anterograde and Retrograde Propagation of Inoculated Human Tau Fibrils and Tau Oligomers in a Non-Transgenic Rat Tauopathy Model
por: Langer Horvat, Lea, et al.
Publicado: (2023)

The Amyloid-Tau-Neuroinflammation Axis in the Context of Cerebral Amyloid Angiopathy
por: Cisternas, Pablo, et al.
Publicado: (2019)

AAV2-mediated GRP78 Transfer Alleviates Retinal Neuronal Injury by Downregulating ER Stress and Tau Oligomer Formation
por: Ha, Yonju, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_nl0klc3mioe3jps5p1v0026ojv